Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Clinical trial NCT06834035 · RECRUITING

Trial details

NCT number: NCT06834035
Sponsor: M. Peter Marinkovich
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Epidermolysis Bullosa Acquisita Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa

Start date: 2025-08-04
Primary completion: 2027-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.